IL16 and COVID-19: This was consistent with previous studies in other organs demonstrating pathogenic IFNγ secretion by recruited T cells and NK cells during SARS-CoV-2 infection50 and increased IL16 and 18 serum/plasma levels in anti-COVID-19 mRNA-vaccine-related myocarditis/pericarditis7,18.